Citadel Advisors
BNGO icon

Citadel Advisors’s Bionano Genomics BNGO Stock Holding History

Citadel Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 14510
2024
Q4 		– Sell
-4,151
Closed -$70.9K – 14528
2024
Q3 		$113K Buy
+4,151
New +$129K ﹤0.01% 10958
2024
Q2 		– Sell
-4,004
Closed -$220K – 14127
2024
Q1 		$267K Buy
4,004
+634
+19% +$47.3K ﹤0.01% 9725
2023
Q4 		$382K Buy
3,370
+3,038
+915% +$317K ﹤0.01% 8663
2023
Q3 		$60.3K Buy
+332
New +$87K ﹤0.01% 11526
2023
Q2 		– Sell
-899
Closed -$406K – 14363
2023
Q1 		$599K Sell
899
-2,368
-72% -$2.1M ﹤0.01% 7948
2022
Q4 		$2.86M Buy
3,267
+1,259
+63% +$1.58M ﹤0.01% 4830
2022
Q3 		$2.21M Sell
2,008
-1,340
-40% -$1.77M ﹤0.01% 5406
2022
Q2 		$2.77M Buy
3,348
+2,061
+160% +$2.12M ﹤0.01% 4895
2022
Q1 		$1.99M Sell
1,287
-4,503
-78% -$6.08M ﹤0.01% 6087
2021
Q4 		$10.4M Buy
5,790
+5,354
+1,228% +$14.3M ﹤0.01% 3017
2021
Q3 		$1.44M Buy
436
+180
+70% +$630K ﹤0.01% 7192
2021
Q2 		$1.13M Sell
256
-3,942
-94% -$15.6M ﹤0.01% 8057
2021
Q1 		$20.4M Buy
+4,198
New +$23.7M 0.01% 1936
2020
Q4 		– Sell
-71
Closed -$28K – 10916
2020
Q3 		$28K Sell
71
-296
-81% -$115K ﹤0.01% 9782
2020
Q2 		$112K Buy
+367
New +$92.2K ﹤0.01% 8929

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Citadel Advisors's BNGO Position: Q1 2025 in Review

Citadel Advisors held its Bionano Genomics (BNGO) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #14510.

Citadel Advisors first reported a position in BNGO in Q2 2020 and has held it in 15 quarters since. The position peaked at $20.4M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Citadel Advisors held 0 shares of Bionano Genomics worth $0 as of Q1 2025.
  • Citadel Advisors left its Bionano Genomics share count unchanged in Q1 2025.
  • Bionano Genomics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2025, its #14510 holding.
  • Citadel Advisors first reported a position in Bionano Genomics in Q2 2020 and has held it in 15 quarters since.
  • Citadel Advisors's Bionano Genomics position peaked at $20.4M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.